The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells

Huang Wei Shen, Yu Lin Chen, Ching Yuh Chern, Wai Ming Kan

研究成果: Article同行評審

6 引文 斯高帕斯(Scopus)

摘要

Phorbol-12-myristate-13-acetate (PMA) induces megakaryocytopoeisis in human erythroleukemia (HEL) cells which is characterized by the increase in cell size, increase in nuclear polyploidization and expression of megakaryocyte marker, CD41. However, upon treatment with 100 nM of selective prostacyclin (IP) agonist beraprost inhibits the induced differentiation. Moreover, selective non-prostanoid IP agonist, BMY 45778 prevents PMA induced megakaryocytopoeisis in HEL cells similarly, while prostaglandin E2 and specific EP3 agonist sulprostone have no effect. Thus, IP receptor is involved. Furthermore, adenylate cyclase activator forskolin and cAMP analog dibutyryl-cAMP also prevented PMA induced megakaryocytopoeisis in HEL cells. Thus, IP agonists inhibition of PMA induced megakaryocytopoeisis in HEL cells may involve a cAMP dependent pathway.

原文English
頁(從 - 到)231-236
頁數6
期刊Prostaglandins and Other Lipid Mediators
83
發行號3 SPEC. ISS.
DOIs
出版狀態Published - 2007 5月

All Science Journal Classification (ASJC) codes

  • 生物化學
  • 生理學
  • 藥理
  • 細胞生物學

指紋

深入研究「The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells」主題。共同形成了獨特的指紋。

引用此